Announcements Trials
Browse Landscape

Phase

Phase NA 25Phase 3 3Phase 4 2Phase 2/3 2Phase 2 1

Status

Unknown 4Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Diseases 1Epstein-Barr Virus Infections 1Carcinoma, Hepatocellular 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Enoxaparin 5Bevacizumab 5Nivolumab 4Carboplatin 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3pembrolizumab 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Control Groups × Clear all
NCT07150624 2026-05-11

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Anhui Provincial Hospital

Phase 4 Recruiting
96 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT04989491 2024-08-19

REPLY

University Hospital, Strasbourg, France

Phase 4 Recruiting
120 enrolled

Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡